April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

April 01, 2025

When Success Isn’t Measured by an Eye Chart

Pediatric refractive surgeon Barry Wasserman, MD, helps his special-needs patients see a brighter future.

Ophthalmology Management

April 01, 2025

Medical Oddities: Shrinking Brains, Failing Hearts?

Brains shrink, bots soothe, tea disappoints, and love gets the hormonal spotlight it deserves this week.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 28, 2025

Triplication of Chromosome 3p24.3p23 in a Child with Autism: What's Your Diagnosis?

Case report highlights a rare 3p24.3p23 triplication in syndromic autism spectrum disorder.

Conexiant

March 27, 2025

Hypoglycemia Cases Tied to Slush Drinks

A new study identifies glycerol intoxication syndrome in children after consuming slush ice drinks, leading to hypoglycemia, metabolic acidosis, and altered consciousness.

Conexiant

March 21, 2025

Vutrisiran Receives FDA Nod for ATTR Amyloidosis With Cardiomyopathy

The FDA approves vutrisiran (Amvuttra) as the first RNAi therapeutic to reduce cardiovascular events and mortality in adults with transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.

Conexiant

March 19, 2025

Medical Oddities: Brain Implants Bugged by Bacteria

Bacteria in the brain, words for longevity, and a fishy fix for kindness—this week in medical oddities.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant